Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Hong Liu-Seifert
Based on 15 articles published since 2010
(Why 15 articles?)
||||
Expertise Level
The expertise of Hong Liu-Seifert ranks in the
  • Top 1.6%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 15 articles on the topic.
Graphical view (beta)
Aliases Liu-Seifert, H   ·   Liu-Seifert, Hong
Work Locations
Details
Most likely:    Eli Lilly Corporation      
2020
  • Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, 46285, USA. · Advanced Analytics Centre, Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD, USA. · Department of Biostatistics, Biogen, Cambridge, MA, USA. · Product Development Biostatistics, Genentech, Inc, South San Francisco, CA, USA. · Neuroscience Statistics, Eli Lilly and Company, Indianapolis, IN, USA. · FDA (ret.), Bethesda, MD, USA. · Biostatistics and Research Decision Sciences, Merck Research Laboratories (MRL), Merck & Co, Inc, Kenilworth, NJ, USA. · Pubmed 32072596
2019
  • 1 Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · 2 Advanced Analytics Centre, Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD, USA. · 3 Department of Biostatistics, Biogen, Cambridge, MA, USA. · 4 Product Development Biostatistics, Genentech, Inc, South San Francisco, CA, USA. · 5 Neuroscience Statistics, Eli Lilly and Company, Indianapolis, IN, USA. · 6 FDA (ret.), Bethesda, MD, USA. · 7 Biostatistics and Research Decision Sciences, Merck Research Laboratories (MRL), Merck & Co, Inc, Kenilworth, NJ, USA. · Pubmed 30983382
2018
  • Hong Liu-Seifert, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana , USA, , Phone: +1 3174330662. · Pubmed 29405226
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
2017
  • a Lilly Research Laboratories , Lilly Corporate Center, Indianapolis , Indiana , USA. · b Pentara Corporation , Salt Lake City , Utah , USA. · c Department of Neurology, University of Southern California , San Diego , California , USA. · Pubmed 28402165
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
2016
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 27239541
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
  • Eli Lilly and Company, Indianapolis, IN, USA. · Quintiles, Inc., Durham, NC, USA. · Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, University of California at San Diego, San Diego, CA, USA. · Pubmed 29854931
  • Eli Lilly and Company, Indianapolis, Indiana, United States of America. · Pubmed 25781335
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
Probable:    Indiana University Indianapolis   Contact    
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
Possible:    McGill University      
2019
  • Serge Gauthier, McGill Center for Studies in Aging, Verdun QC, Canada, · Pubmed 31062826
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 15 total) written by Hong Liu-Seifert about Alzheimer Disease:

  • Disease Modification in Alzheimer's Disease: Current Thinking. 2020
  • Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force. 2019
  • Disease Modification in Alzheimer's Disease: Current Thinking. 2019
  • Delayed-Start Analyses in the Phase 3 Solanezumab EXPEDITION3 Study in Mild Alzheimer's Disease. 2018
  • Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. 2018
  • Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer's Disease in EXPEDITION 3. 2018
  • Statistical properties of continuous composite scales and implications for drug development. 2017
  • Assessing quality of life in Alzheimer's disease: Implications for clinical trials. 2017
  • Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. 2016
  • Function and clinical meaningfulness of treatments for mild Alzheimer's disease. 2016
Show List of Full Article Records
Google Searches

Learn more about Hong Liu-Seifert using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Eli Lilly Corporation
Indiana University Indianapolis
McGill University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Eli Lilly Corporation
2020
  • Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN, 46285, USA. · Advanced Analytics Centre, Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD, USA. · Department of Biostatistics, Biogen, Cambridge, MA, USA. · Product Development Biostatistics, Genentech, Inc, South San Francisco, CA, USA. · Neuroscience Statistics, Eli Lilly and Company, Indianapolis, IN, USA. · FDA (ret.), Bethesda, MD, USA. · Biostatistics and Research Decision Sciences, Merck Research Laboratories (MRL), Merck & Co, Inc, Kenilworth, NJ, USA. · Pubmed 32072596
2019
  • 1 Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · 2 Advanced Analytics Centre, Biometrics and Information Sciences, AstraZeneca, Gaithersburg, MD, USA. · 3 Department of Biostatistics, Biogen, Cambridge, MA, USA. · 4 Product Development Biostatistics, Genentech, Inc, South San Francisco, CA, USA. · 5 Neuroscience Statistics, Eli Lilly and Company, Indianapolis, IN, USA. · 6 FDA (ret.), Bethesda, MD, USA. · 7 Biostatistics and Research Decision Sciences, Merck Research Laboratories (MRL), Merck & Co, Inc, Kenilworth, NJ, USA. · Pubmed 30983382
2018
  • Hong Liu-Seifert, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana , USA, , Phone: +1 3174330662. · Pubmed 29405226
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
2017
  • a Lilly Research Laboratories , Lilly Corporate Center, Indianapolis , Indiana , USA. · b Pentara Corporation , Salt Lake City , Utah , USA. · c Department of Neurology, University of Southern California , San Diego , California , USA. · Pubmed 28402165
  • Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. · Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. · Pubmed 28229126
2016
  • Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: · Eli Lilly and Company, Indianapolis, IN, USA. · Avid Radiopharmaceuticals, Philadelphia PA, USA. · Pubmed 26238576
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Pubmed 27239541
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
  • Eli Lilly and Company, Indianapolis, IN, USA. · Quintiles, Inc., Durham, NC, USA. · Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Alzheimer's Disease Cooperative Study, Department of Neurosciences, University of California at San Diego, San Diego, CA, USA. · Pubmed 29854931
  • Eli Lilly and Company, Indianapolis, Indiana, United States of America. · Pubmed 25781335
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
Indiana University Indianapolis
2018
  • From the Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.) · Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III-Paul Sabatier, Toulouse, France (B.V.) · Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC - both in Australia (M.W.) · Fundació ACE, Alzheimer Research Center and Memory Clinic, Institut Català de Neurociències Aplicades, Barcelona (M. Boada) · Kingshill Research Centre, Victoria Hospital, Swindon, United Kingdom (R.B.) · the Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (M. Borrie) · Clinic for Medicine of the Elderly, Diakovere Henriettenstift, Hannover, Germany (K.H.) · Karolinska Institutet Alzheimer's Disease Research Center and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden (N.A.) · the Department of Pathophysiology and Transplantation, Neurology Unit, Dino Ferrari Center, University of Milan, Fondazione Ca' Granda, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico, Milan (E. Scarpini) · Eli Lilly (H.L.-S., M.C., A.H., K.S., V.P.H., C.C., R.K., M.M., R.D., K.J.S., E. Siemers) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (R.A.D.) - both in Indianapolis · and Avid Radiopharmaceuticals, Philadelphia (M.M.). · Pubmed 29365294
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
McGill University
2019
  • Serge Gauthier, McGill Center for Studies in Aging, Verdun QC, Canada, · Pubmed 31062826
Yearly article counts 12322410000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.